Navigation Links
Spherix Announces Post-Hoc Analysis of Phase 3 Trial With D-Tagatose in Diabetes
Date:12/2/2010

BETHESDA, Md., Dec. 2, 2010 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.

The first post hoc analysis done of the Biospherics Phase 3 NEET clinical trial suggests that the larger reduction in HbA1c observed in the Per Protocol population in the USA may be the result of D-tagatose acting at the level of metabolic control mediated by adipocytes (fat cells). In other words, in patients with sufficient numbers and size of adipocytes for dietary carbohydrate effects to be manifested, there is a role for adipocytes in the mechanism of D-tagatose in the control of blood glucose and plasma triglyceride levels.

"Tagatose appears to be more effective in Type 2 diabetes patients with adipocyte dysfunction that no longer permits the adipocytes to act appropriately as an endocrine organ controlling HbA1c," said Dr. Robert Lodder, President of Spherix.

Results from the first post hoc analysis of the Biospherics Phase 3 70971-004 clinical trial showed a correlation between HbA1c and BMI through all of the monthly visits (v1-v14) in the trial (see Table 1). Results of the Phase 3 trial, as previously reported, showed a greater lowering of HbA1c with tagatose treatment in patients from the US cohort (-1.1 vs. placebo at 10 months of therapy in the Per Protocol population) compared with India (-0.2 vs. placeb
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. Spherix D-tagatose to be Supplied by Inalco SpA
4. Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
5. Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
6. Spherix Elects New Independent Director, and Elects Chairman of the Board
7. Spherix Reports First Quarter 2009 Earnings
8. Spherix Announces Positive Phase 2 Study Results
9. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
10. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
11. Spherix Reports Third Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 27, 2015 Levi & Korsinsky announces it ... OHRP ) concerning possible violations of federal securities ... Company in connection with its study of the drug ... or contact Joseph E. Levi, Esq. ... telephone at (212) 363-7500, toll-free: (877) 363-5972. ...
(Date:3/27/2015)... /PRNewswire/ - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) announces ... grant of an aggregate of 236,070 options to certain ... the Company pursuant to the Company,s Stock Option Plan. ... the tenth anniversary of the date of grant, 5,000 ... the date of grant and 50,000 are set to ...
(Date:3/27/2015)... /CNW Telbec/ - Russell Williams , President of ... welcomes the 2015-2016 Quebec Budget, noting the fiscal discipline ... biopharmaceutical industry. However, the association is concerned about the ... the government,s intent to strive for a balanced budget ... Quebec,s economic development is encouraging," ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3
... DHAKA, Bangladesh, Feb. 7, 2011 ... million people served by just 11 modern radiotherapy linear ... Varian Medical Systems (NYSE: VAR). Treatments using fast and ... a new Clinac® iX medical linear accelerator at the ...
... 7, 2011 Amarin Corporation plc (Nasdaq: AMRN ... the Leerink Swann Hot Topics in Therapeutics Roundtable Conference on ... discussion on Cardiology at 7:45am ET and a company presentation ... Roosevelt Hotel in New York City. A live ...
Cached Medicine Technology:Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 2Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 3Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference 2
(Date:3/28/2015)... 2015 Purity Products®, a leading ... the release of their revolutionary new weight loss ... randomized, double-blind, placebo-controlled clinical studies to be effective ... size. MuffinStop™ is a combination of two traditionally ... fused together to create one of the most ...
(Date:3/27/2015)... Red Deer, Alberta (PRWEB) March 27, 2015 ... had, until then, prevented her from working, Monica K. arrived ... day in the mending department quiet, defensive and scared. The ... Employment Placement & Support Services (EPSS) to offer jobs ... it does take patience and a willingness to begin with ...
(Date:3/27/2015)... York, NY (PRWEB) March 27, 2015 ... seeing more plastic surgery patients travel to the Dominican ... Medina. The plastic surgery clinic is turning the medical ... international cosmetic surgery patients — with trustworthy services becoming ... factor when selecting a plastic surgeon. Patients are not ...
(Date:3/27/2015)... San Jose, CA (PRWEB) March 27, 2015 ... last week’s 2015 GPU technology conference (GTC) , the ... to fight cancer and push the human lifespan well beyond ... Baltimore MD informatics company , is one of 12 ... , While other startups in the GTC Emerging ...
(Date:3/27/2015)... March 27, 2015 Endure Yoga is ... functional fitness athletes. This new program matches yoga poses ... for post-workout cool down. This program utilizes yoga to ... and mental focus. , Karen Lefurgy, competitive athlete ... yoga long before I started Crossfit® training, but quickly, ...
Breaking Medicine News(10 mins):Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 2Health News:Red Deer Uniforms Shop Celebrates 3rd Year Sewing Hope for the Challenged 3Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2
... The Center for ... with the flu (influenza). On average, the influenza virus leads to 20,000 to 40,000 American ... deaths by offering free flu shots . , ... Plano, TX (Vocus) September 12, 2009 -- Starting Monday, September 14th, the Plano location ...
... Hernandez, Ph.D., M.P.H.an assistant professor at the University of ... that body mass in younger and older adulthood, and ... man,s risk for prostate cancer. This risk varies among ... study published in Cancer Epidemiology, Biomarkers & Prevention ...
... , TAMPA, Fla. and SAN FRANCISCO, Sept. ... agreement to roll out Demandforce D3, a web-based patient communications ... in Florida and Georgia. Coast Dental, the leading dental provider ... pilot. , , Coast Dental integrated the ...
... NEW YORK, Sept. 11 Duane Reade Holdings Inc., ... as the Local Presenting Sponsor of the 2009 Komen New York ... foundation, The Duane Reade Charitable Foundation, have raised $330,000 to increase ... find a cure. This marks the third year that Duane Reade ...
... , LIONVILLE, Pa., Sept. 11 ... that Donald E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, ... 7th Annual Best Ideas Conference 2009, being held September 16-17, 2009 ... the UBS Global Life Sciences Conference, being held September 21-23, 2009 ...
... ROCHESTER, Minn., Sept. 11 Mayo Clinic researchers ... may help them diagnose cardiac infections without an invasive exam. ... on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. , ... ) , , Endocarditis -- an infection ...
Cached Medicine News:Health News:H1N1 frenzy may allow regular flu to be more deadly than ever 2Health News:University of Hawaii at Manoa CRCH scientists report adulthood body size associated with cancer risk 2Health News:Coast Dental Deploys Demandforce D3 Communications Platform 2Health News:New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure(R) 2Health News:New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure(R) 3Health News:West to Present at Two Upcoming Investor Conferences 2Health News:Artificial Intelligence Helps Diagnose Cardiac Infections 2Health News:Artificial Intelligence Helps Diagnose Cardiac Infections 3
... the examination of the anatomical conditions in the ... expanse and form of the iridocorneal angle can ... beam. The slit lamp 900, with its swivelling ... an assessment of the expanse of the entire ...
An antegrade femoral nail....
... WH, the latest in the Magnes line of ... and its full cortical coverage, provides the highest ... allowing study of a wide range of neuronal ... choice of detector configurations and can be equipped ...
... stimulation is a non-invasive and painless method ... system. Cadwell Laboratories manufactures two magnetic stimulation ... Magnetic Stimulator (HSMS). The Hight ... stimulation rates up to 25 Hz at ...
Medicine Products: